After an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare Advantage and drug plans, the Biden administration hopes to unleash a special weapon to make sure companies follow the new rules: you.
Bias Capital Cancels $25M Investment in Parker Health Amid Fraud Concerns
What You Should Know: – Bias Capital, an angel syndicate, today announced the cancellation of its $25M Series A investment in healthcare technology company Parker